SEC Form 4 · accession 0001645627-18-000019
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 2, 2018
Accepted (ET)
Apr 6, 2018 · 8:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2018 | P | 1,000 | $0.0344 | A | 24,923,689 | D | |
| Common Stock | Apr 3, 2018 | P | 2,000 | $0.0338 | A | 24,925,689 | D | |
| Common Stock | Apr 3, 2018 | P | 1,000 | $0.0342 | A | 24,926,689 | D | |
| Common Stock | Apr 4, 2018 | P | 1,000 | $0.0344 | A | 24,927,689 | D | |
| Common Stock | Apr 4, 2018 | P | 1,000 | $0.0344 | A | 24,928,689 | D | |
| Common Stock | Apr 4, 2018 | P | 2,000 | $0.034 | A | 24,930,689 | D | |
| Common Stock | Apr 4, 2018 | P | 2,000 | $0.034 | A | 24,932,689 | D | |
| Common Stock | Apr 4, 2018 | P | 1,000 | $0.034 | A | 24,933,689 | D | |
| Common Stock | Apr 4, 2018 | P | 1,000 | $0.034 | A | 24,934,689 | D | |
| Common Stock | Apr 5, 2018 | P | 1,000 | $0.034 | A | 24,935,689 | D | |
| Common Stock | Apr 5, 2018 | P | 1,000 | $0.0331 | A | 24,936,689 | D | |
| Common Stock | Apr 6, 2018 | P | 1,000 | $0.0342 | A | 24,937,689 | D | |
| Common Stock | Apr 6, 2018 | P | 1,000 | $0.0375 | A | 24,938,689 | D | |
| Common Stock | Apr 6, 2018 | P | 1,000 | $0.0359 | A | 24,939,689 | D |
Table II — derivative securities
No Table II lines on this filing.